Related Experiment Video
Updated: Apr 25, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Diabetes Diagnosis Patterns in Medicaid: How State Policy, Managed Care, and Social Vulnerability Shape Detection in
Maria L Alva1, Slun Booppasiri2, Alexander Crowell3
1Department of Health Management and Policy, Georgetown University, Washington, DC.
Objective:
To describe patterns of type 2 diabetes diagnosis prevalence in Medicaid administrative data by individual and contextual factors.
Methods:
Diagnosed prevalence was estimated using the 2016-2021 Transformed Medicaid Statistical Information System (T-MSIS) and a Bayesian multilevel regression framework. The first level included patient characteristics (age, sex, and race/ethnicity), the Social Vulnerability Index (SVI), plan-level characteristics, payment models, and federal level of poverty (FLP) eligibility thresholds. The second level incorporates partial pooling over the state to model state fixed effects. Adults ages 21-64 years with 24+ months consecutive enrollment were included. States with a high degree of missing data were excluded.
Results:
Among 4.41 million eligible Medicaid beneficiaries in N=11 states with high-quality T-MSIS data, 10.3% had a type 2 diabetes diagnosis record. State-level diagnosed prevalence based on administrative data ranged from 6.5%-13.0%, and increased with age (4.1% for 21-35 vs. 23.9% for 55-64 y), was higher among "Other" race (14.3%), Hispanic (12.0%), and Black (10.9%) enrollees versus White (9.1%). Higher county-level obesity was associated with increased odds (third vs. first tertile OR 1.26, 95% CI: 1.25-1.27), while living in urban areas (OR 0.91, 95% CI: 0.90-0.91) and in the highest SVI quartile (OR 0.74, 95% CI: 0.73-0.75) with lower odds. Race interactions were most pronounced for contextual socioeconomic modifiers (SVI, FPL, and plan type).
Conclusions:
Evidence generated confirms that odds of having a recorded type 2 diabetes diagnosis are shaped by age, comorbidities, race/ethnicity, and social vulnerability. Notable variations by state and care plans were identified. Documentation and data improvements are needed.
More Related Videos
06:46A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes III: Clinical Manifestations